摘要
目的:重组表达人冠状病毒NL63(HCoV-NL63)的核壳蛋白(N蛋白)及棘突蛋白(S蛋白),用于检测血清中的相应抗体。方法:用原核表达系统表达HCoV-NL63的N蛋白,建立检测N抗体的Werstern印迹法;用真核表达系统表达HCoV-NL63的S蛋白,建立检测S抗体的间接免疫荧光(IFA)法。结果:经Werstern印迹检测,重组S蛋白和N蛋白表达正确;初步建立了N蛋白纯化方法。利用建立的检测方法,检测了100份正常成人血清,总阳性率为81%。其中S抗体阳性率为66%,N抗体阳性率为38%,S抗体和N抗体均为阳性的占总数的22%,双抗体均为阴性的占总数的19%;S抗体的检出率明显高于N抗体。结论:重组HCoV-NL63N蛋白及S蛋白表达成功;S抗体和N抗体共同检测可获得较好的检测结果,减少漏检。
Objective:To express the human coronavirus NL63 (HCoV-NL63) nucleocapsid protein (N protein) and the spike protein (S protein) for the detection of serum antibodies.Methods:The recombinant N protein and S protein of HCoV-NL63 were expressed in the prokaryotic and eukaryotic expression system respectively.The N antibody and S antibody in serum were detected by Werstern blot method and indirect immunofluorescence assay (IFA) based on recombinant N protein and S protein respectively.Results:The expression of recombinant N protein and S protein were confirmed by Werstern blot,and the purified N protein was obtained.The N antibody and S antibody in sera from 100 normal adults were detected by Werstern blot and IFA,and the total positive rate was 81%.Where S antibody positive rate was 66%,N antibody positive rate was 38%,both S antibody and N antibody were positive in 22% of the total,both were negative in 19% of the total.S antibody detection rate was significantly higher than N antibody.Conclusion:The recombinant N protein and S protein of HCoV-NL63 were obtained.The detection sensitivity is higer when both of antibody assays are applied,reducing false negatives.
出处
《生物技术通讯》
CAS
2010年第2期154-157,共4页
Letters in Biotechnology
基金
国家"十一五"重大专项(2008ZX10004-014)
国家高技术研究发展计划(2007AA02Z463
2007AA02Z464)
关键词
人冠状病毒NL63
核壳蛋白
棘突蛋白
表达
血清学检测
human coronavirus NL63 nucleocapsid protein spike protein expression serological detection